Correlation Engine 2.0
Clear Search sequence regions


  • 1A3 (1)
  • 4 hydroxytamoxifen (3)
  • bisphenol (7)
  • breast cancer (1)
  • cellular (1)
  • CYP2B6 (1)
  • CYP2C19 (4)
  • CYP2D6 (1)
  • CYP3A4 (1)
  • CYPs (1)
  • e e (1)
  • estrogen (8)
  • estrogen receptor (1)
  • gene (4)
  • glucuronides (2)
  • human (2)
  • liver (2)
  • n desmethyltamoxifen (2)
  • P 450 (2)
  • P450 (1)
  • phase (1)
  • phenols (2)
  • protein human (1)
  • rifampicin (1)
  • rt pcr (1)
  • tamoxifen (15)
  • UGT1A8 (1)
  • UGT2B7 (1)
  • ugt2b7 protein, human (1)
  • Sizes of these terms reflect their relevance to your search.

    Tamoxifen, a standard therapy for breast cancer, is metabolized to compounds with anti-estrogenic as well as estrogen-like action at the estrogen receptor. Little is known about the formation of estrogen-like metabolites and their biological impact. Thus, we characterized the estrogen-like metabolites tamoxifen bisphenol and metabolite E for their metabolic pathway and their influence on cytochrome P450 activity and ADME gene expression. The formation of tamoxifen bisphenol and metabolite E was studied in human liver microsomes and Supersomes™. Cellular metabolism and impact on CYP enzymes was analyzed in upcyte® hepatocytes. The influence of 5 µM of tamoxifen, anti-estrogenic and estrogen-like metabolites on CYP activity was measured by HPLC MS/MS and on ADME gene expression using RT-PCR analyses. Metabolite E was formed from tamoxifen by CYP2C19, 3A and 1A2 and from desmethyltamoxifen by CYP2D6, 1A2 and 3A. Tamoxifen bisphenol was mainly formed from (E)- and (Z)-metabolite E by CYP2B6 and CYP2C19, respectively. Regarding phase II metabolism, UGT2B7, 1A8 and 1A3 showed highest activity in glucuronidation of tamoxifen bisphenol and metabolite E. Anti-estrogenic metabolites (Z)-4-hydroxytamoxifen, (Z)-endoxifen and (Z)-norendoxifen inhibited the activity of CYP2C enzymes while tamoxifen bisphenol consistently induced CYPs similar to rifampicin and phenobarbital. On the transcript level, highest induction up to 5.6-fold was observed for CYP3A4 by tamoxifen, (Z)-4-hydroxytamoxifen, tamoxifen bisphenol and (E)-metabolite E. Estrogen-like tamoxifen metabolites are formed in CYP-dependent reactions and are further metabolized by glucuronidation. The induction of CYP activity by tamoxifen bisphenol and the inhibition of CYP2C enzymes by anti-estrogenic metabolites may lead to drug-drug-interactions.

    Citation

    Janina Johänning, Patrick Kröner, Maria Thomas, Ulrich M Zanger, Astrid Nörenberg, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch, Werner Schroth, Thomas E Mürdter. The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes. Archives of toxicology. 2018 Mar;92(3):1099-1112

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 29285606

    View Full Text